Promaxo, Inc., said today that it closed a $3.5 million Series A round to fund its clinical validation and regulatory efforts for the company’s office-based, high-resolution MRI. MicroPort Scientific led the round and in connection with its investment, MicroPort was given exclusive manufacturing and distribution rights for Promaxo’s MRI tech in China. The company has […]
Oncology
Pulse Biosciences raises $30m in private placement
Pulse Biosciences (NSDQ:PLSE) said today that it agreed to sell 2 million of the company’s common stock at $15.02 apiece to investor Robert Duggan in a $30 million private placement. The company plans to use the net proceeds from the private placement for working capital or other general corporate purposes, according to a regulatory filing. Earlier […]
ASTRO ’17 Round-up: Novocure touts five-year results for Optune, chemo combo in newly-diagnosed glioblastoma patients
Novocure (NSDQ:NVCR) touted data today from the Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-diagnosed glioblastoma. The analyses were presented at the American Society for Radiation Oncology’s 2017 annual meeting in San Diego. Get the full story at our sister site, Drug Delivery Business News.
Mevion files for FDA clearance for S250i proton therapy system
Mevion Medical Systems said yesterday it submitted a 510(k) premarket notification to the FDA for its Mevion S250i proton therapy system with Hyperscan pencil beam scanning tech. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said. “We focused […]
CIRSE 2017 Round-up: Delcath touts second-gen hemofiltration system in percutaneous hepatic perfusion
Delcath Systems (NSDQ:DCTH) touted data today from a study of its second-generation hemofiltration system in patients undergoing percutaneous hepatic perfusion with melphalan hydrochloride. The New York-based company presented the results from its study at the Cardiology and Interventional Radiology of Europe annual meeting in Copenhagen, Denmark. The investigational product, an injectable melphalan hydrochloride for use with […]
Endomag wins CE Mark for Magseed MIS breast cancer guide, inks 5-year distro deal
UK-based surgical guidance company Endomag said this week it won CE Mark approval in the European Union for its Magseed minimally invasive breast marker and that it inked a 5-year distribution deal with Sysmex. The company’s Magseed is designed to mark tumor sites with a ‘seed’, which it says is smaller than a grain of […]
Pulse Biosciences pulls, plans to refile FDA 510(k) clearance bid for PulseTx nanostim
Pulse Biosciences (NSDQ:PLSE) said today it withdrew its FDA 510(k) application for its PulseTX nano-pulse stimulation platform, but said it has plans to resubmit the application “in the coming months.” The Burlingame, Calif.-based company’s PulseTx system uses short-duration electrical pulses directed at solid tumors to induce immunogenic cell death. The cell death process exposes the tumor […]
Report: Handheld ‘pen’ device designed to detect cancer cells in seconds
A newly designed “pen” device can detect cancer cells within a matter of seconds to help surgeons more fully remove tumors, according to an NBC News report. The MasSpec Pen is designed to use a drop of water to make its analysis in real time, and does not require cutting any tissue, according to the […]
Report: IBM’s Watson for Oncology not living up to “lofty expectations”
UPDATE: Updated to indicate that IBM’s Watson for Oncology is not trying to find a cure for cancer, only treatments. After 3 years on the market, IBM’s Watson for Oncology is not living up to the hype it’s been sold under in its battle to find the best treatment for cancer, according to a new […]
Lumicell launches breast cancer, prostate cancer trials with Lum image-guided system
Lumicell said today that it is launching clinical studies in breast cancer and prostate cancer with its Lum image-guided cancer surgery system. The breast cancer trial is a pivotal study following an initial training period with surgeons, the Wellesley, Mass.-based company reported, and the prostate cancer study is a first for Lumicell and its technology, Most […]
Hologic launches Brevera real-time breast biopsy system
Hologic (NSDQ:HOLX) said today it launched its Brevera breast biopsy system designed for real-time breast biopsy and verification. The Marlborough company’s Brevera system features CorLumina imaging technology to streamline the biopsy process and enhance workflow, the company said. The device is intended to increase biopsy accuracy and deliver results at the point of care for more informed […]